Chan et al. found the RASSF1A gene hyper methylated in 93% of the sera of HBV-related HCC patients and in 58% of the sera of HBV chronic infected patients suggesting that RASSF1A hypermethylation could represent an early event in HCC pathogenesis [31]. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.